Home › Funds › Two Sigma Investments › RAPP
Two Sigma Investments position in RAPP
RAPPORT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)24.47K sh
Reported value held$1.02M
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 13.00K | $302.38K | New |
| Q1 2025 | 33.76K | $338.58K | New |
| Q2 2025 | 19.74K | $224.48K | Reduce |
| Q3 2025 | 21.50K | $638.55K | Add |
| Q4 2025 | 50.62K | $1.54M | Add |
| Q1 2026 | 28.10K | $879.34K | Reduce |
| Q2 2026 | 24.47K | $1.02M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RAPP
- Fidelity Management & Research (FMR) 7.17M sh · $298.89M · Q2 2026
- Goldman Sachs Group 2.91M sh · $121.28M · Q2 2026
- BlackRock Inc 2.70M sh · $112.50M · Q2 2026
- Vanguard Group 1.82M sh · $55.15M · Q4 2025
- Geode Capital Management 793.45K sh · $33.07M · Q2 2026
- Capital World Investors 551.66K sh · $22.99M · Q2 2026
- Morgan Stanley 297.61K sh · $12.40M · Q2 2026
- Northern Trust Corp 277.31K sh · $11.56M · Q2 2026
- Charles Schwab Investment Management 246.81K sh · $10.28M · Q2 2026
- Invesco Ltd 215.24K sh · $8.97M · Q2 2026
- D. E. Shaw & Co 214.83K sh · $8.95M · Q2 2026
- Millennium Management 154.91K sh · $6.46M · Q2 2026